{"id":1913,"date":"2026-02-26T17:08:32","date_gmt":"2026-02-26T22:08:32","guid":{"rendered":"https:\/\/global-pharma.com.co\/?p=1913"},"modified":"2026-06-18T14:51:24","modified_gmt":"2026-06-18T19:51:24","slug":"nueva-norma-regulacion-medicamentos-2026","status":"publish","type":"post","link":"https:\/\/global-pharma.com.co\/es\/nueva-norma-regulacion-medicamentos-2026\/","title":{"rendered":"Colombia actualiza el Decreto 677 de 1995 tras tres d\u00e9cadas de vigencia en la regulaci\u00f3n de medicamentos"},"content":{"rendered":"\n

30 a\u00f1os de espera han terminado<\/strong> Colombia finalmente est\u00e1 actualizando el Decreto 677 de 1995<\/strong>, la norma maestra de medicamentos que llevaba tres d\u00e9cadas sin una reforma estructural. No es solo un cambio legal; es el fin de un anacronismo. En un mundo donde la ciencia vuela, nuestro sistema de salud no pod\u00eda seguir operando con las reglas del siglo pasado. Hoy, damos el paso decisivo para alinear nuestra regulaci\u00f3n con la medicina del 2026<\/p>\n\n\n\n

Los 4 pilares de la transformaci\u00f3n: Esta actualizaci\u00f3n, impulsada por el Ministerio de Salud y bajo la lupa de actores clave como Afidro, busca resolver cuellos de botella cr\u00edticos:<\/p>\n\n\n\n

    \n
  1. Agilidad que salva vidas:<\/strong> El nuevo marco busca simplificar y acelerar los procesos de registro sanitario ante el Invima. En salud, el tiempo es el recurso m\u00e1s valioso; reducir los meses (o a\u00f1os) de espera para que una terapia innovadora entre al pa\u00eds se traduce directamente en vidas salvadas.<\/li>\n\n\n\n
  2. Convergencia con est\u00e1ndares mundiales:<\/strong> Colombia aspira a hablar el mismo idioma que las grandes agencias regulatorias como la FDA (EE. UU.) o la EMA (Europa). Esto facilita el reconocimiento de datos cient\u00edficos internacionales y posiciona al pa\u00eds como un destino serio y confiable para la inversi\u00f3n en investigaci\u00f3n cl\u00ednica.<\/li>\n\n\n\n
  3. Seguridad jur\u00eddica para la innovaci\u00f3n:<\/strong> La claridad en las reglas de juego es el combustible del progreso. Un decreto moderno garantiza que las empresas de biotecnolog\u00eda y los laboratorios de investigaci\u00f3n puedan operar en un entorno predecible, fomentando la llegada de nuevos desarrollos tecnol\u00f3gicos al territorio nacional.<\/li>\n\n\n\n
  4. Monitoreo y Farmacovigilancia 2.0:<\/strong> No se trata solo de que los medicamentos entren r\u00e1pido, sino de que su seguimiento sea impecable. La reforma refuerza los mecanismos de control post-comercializaci\u00f3n, asegurando que cada f\u00e1rmaco cumpla con los est\u00e1ndares de calidad durante todo su ciclo de vida.<\/li>\n<\/ol>\n\n\n\n

    El reto de la implementaci\u00f3n:<\/strong><\/p>\n\n\n\n

    La norma es el primer paso, pero la ejecuci\u00f3n lo es todo. El \u00e9xito de este nuevo decreto depender\u00e1 de la capacidad de nuestras instituciones para adoptar estos cambios con eficiencia y transparencia. Estamos ante una oportunidad \u00fanica de convertir a Colombia en un hub de innovaci\u00f3n sanitaria para Am\u00e9rica Latina.<\/p>\n\n\n\n

    Fuente: <\/strong>https:\/\/afidro.org\/2026\/02\/19\/sabias-que-colombia-esta-actualizando-un-decreto-de-medicamentos-con-mas-de-30-anos\/<\/strong><\/a><\/p>\n\n\n\n

    <\/p>\n","protected":false},"excerpt":{"rendered":"

    Tras 30 a\u00f1os sin reformas estructurales, Colombia actualiza el Decreto 677 de 1995 para modernizar la regulaci\u00f3n de medicamentos. Esta iniciativa busca acelerar los registros sanitarios en el Invima, converger con est\u00e1ndares internacionales de la FDA y la EMA, y fortalecer la farmacovigilancia, impulsando la competitividad del sector de la salud.<\/p>\n","protected":false},"author":3,"featured_media":2079,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_joinchat":[],"footnotes":""},"categories":[6],"tags":[],"class_list":["post-1913","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nColombia actualiza decreto maestro de medicamentos<\/title>\n<meta name=\"description\" content=\"El Ministerio de Salud actualiza el Decreto 677 de 1995 para agilizar los registros ante el Invima y alinear el pa\u00eds con agencias mundiales.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/global-pharma.com.co\/es\/nueva-norma-regulacion-medicamentos-2026\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Colombia actualiza decreto maestro de medicamentos\" \/>\n<meta property=\"og:description\" content=\"El Ministerio de Salud actualiza el Decreto 677 de 1995 para agilizar los registros ante el Invima y alinear el pa\u00eds con agencias mundiales.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/global-pharma.com.co\/es\/nueva-norma-regulacion-medicamentos-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Global Pharma & Logistic S.A.S.\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-26T22:08:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-18T19:51:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/02\/Presentacion-Comercial-Global-Pharma-Logistic-6.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mar\u00eda Camila Sanchez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mar\u00eda Camila Sanchez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/\"},\"author\":{\"name\":\"Mar\u00eda Camila Sanchez\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/person\\\/912625696b849a3374bc496e1df87a7c\"},\"headline\":\"Colombia actualiza el Decreto 677 de 1995 tras tres d\u00e9cadas de vigencia en la regulaci\u00f3n de medicamentos\",\"datePublished\":\"2026-02-26T22:08:32+00:00\",\"dateModified\":\"2026-06-18T19:51:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/\"},\"wordCount\":396,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Presentacion-Comercial-Global-Pharma-Logistic-6.png\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"es-CO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/\",\"name\":\"Colombia actualiza decreto maestro de medicamentos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Presentacion-Comercial-Global-Pharma-Logistic-6.png\",\"datePublished\":\"2026-02-26T22:08:32+00:00\",\"dateModified\":\"2026-06-18T19:51:24+00:00\",\"description\":\"El Ministerio de Salud actualiza el Decreto 677 de 1995 para agilizar los registros ante el Invima y alinear el pa\u00eds con agencias mundiales.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/#breadcrumb\"},\"inLanguage\":\"es-CO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-CO\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Presentacion-Comercial-Global-Pharma-Logistic-6.png\",\"contentUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Presentacion-Comercial-Global-Pharma-Logistic-6.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/nueva-norma-regulacion-medicamentos-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/global-pharma.com.co\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Colombia actualiza el Decreto 677 de 1995 tras tres d\u00e9cadas de vigencia en la regulaci\u00f3n de medicamentos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#website\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/\",\"name\":\"Distribuidor de materias primas farmac\u00e9uticas en Colombia.\",\"description\":\"Principios Activos y Materias Primas en Colombia\",\"publisher\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/global-pharma.com.co\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-CO\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\",\"name\":\"Global Pharma & Logistic S.A.S.\",\"alternateName\":\"Global Pharma & Logistic S.A.S.\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-CO\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/LOGO-COMPLETO2-02.jpg\",\"contentUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/LOGO-COMPLETO2-02.jpg\",\"width\":2133,\"height\":2133,\"caption\":\"Global Pharma & Logistic S.A.S.\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/51710617\\\/admin\\\/dashboard\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/person\\\/912625696b849a3374bc496e1df87a7c\",\"name\":\"Mar\u00eda Camila Sanchez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-CO\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"caption\":\"Mar\u00eda Camila Sanchez\"},\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/es\\\/author\\\/maria-sanchez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Colombia actualiza decreto maestro de medicamentos","description":"El Ministerio de Salud actualiza el Decreto 677 de 1995 para agilizar los registros ante el Invima y alinear el pa\u00eds con agencias mundiales.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/global-pharma.com.co\/es\/nueva-norma-regulacion-medicamentos-2026\/","og_locale":"es_ES","og_type":"article","og_title":"Colombia actualiza decreto maestro de medicamentos","og_description":"El Ministerio de Salud actualiza el Decreto 677 de 1995 para agilizar los registros ante el Invima y alinear el pa\u00eds con agencias mundiales.","og_url":"https:\/\/global-pharma.com.co\/es\/nueva-norma-regulacion-medicamentos-2026\/","og_site_name":"Global Pharma & Logistic S.A.S.","article_published_time":"2026-02-26T22:08:32+00:00","article_modified_time":"2026-06-18T19:51:24+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/02\/Presentacion-Comercial-Global-Pharma-Logistic-6.png","type":"image\/png"}],"author":"Mar\u00eda Camila Sanchez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Mar\u00eda Camila Sanchez","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/#article","isPartOf":{"@id":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/"},"author":{"name":"Mar\u00eda Camila Sanchez","@id":"https:\/\/global-pharma.com.co\/#\/schema\/person\/912625696b849a3374bc496e1df87a7c"},"headline":"Colombia actualiza el Decreto 677 de 1995 tras tres d\u00e9cadas de vigencia en la regulaci\u00f3n de medicamentos","datePublished":"2026-02-26T22:08:32+00:00","dateModified":"2026-06-18T19:51:24+00:00","mainEntityOfPage":{"@id":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/"},"wordCount":396,"commentCount":0,"publisher":{"@id":"https:\/\/global-pharma.com.co\/#organization"},"image":{"@id":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/02\/Presentacion-Comercial-Global-Pharma-Logistic-6.png","articleSection":["Blog"],"inLanguage":"es-CO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/","url":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/","name":"Colombia actualiza decreto maestro de medicamentos","isPartOf":{"@id":"https:\/\/global-pharma.com.co\/#website"},"primaryImageOfPage":{"@id":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/#primaryimage"},"image":{"@id":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/02\/Presentacion-Comercial-Global-Pharma-Logistic-6.png","datePublished":"2026-02-26T22:08:32+00:00","dateModified":"2026-06-18T19:51:24+00:00","description":"El Ministerio de Salud actualiza el Decreto 677 de 1995 para agilizar los registros ante el Invima y alinear el pa\u00eds con agencias mundiales.","breadcrumb":{"@id":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/#breadcrumb"},"inLanguage":"es-CO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/"]}]},{"@type":"ImageObject","inLanguage":"es-CO","@id":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/#primaryimage","url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/02\/Presentacion-Comercial-Global-Pharma-Logistic-6.png","contentUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/02\/Presentacion-Comercial-Global-Pharma-Logistic-6.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/global-pharma.com.co\/nueva-norma-regulacion-medicamentos-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/global-pharma.com.co\/"},{"@type":"ListItem","position":2,"name":"Colombia actualiza el Decreto 677 de 1995 tras tres d\u00e9cadas de vigencia en la regulaci\u00f3n de medicamentos"}]},{"@type":"WebSite","@id":"https:\/\/global-pharma.com.co\/#website","url":"https:\/\/global-pharma.com.co\/","name":"Distribuidor de materias primas farmac\u00e9uticas en Colombia.","description":"Principios Activos y Materias Primas en Colombia","publisher":{"@id":"https:\/\/global-pharma.com.co\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/global-pharma.com.co\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-CO"},{"@type":"Organization","@id":"https:\/\/global-pharma.com.co\/#organization","name":"Global Pharma & Logistic S.A.S.","alternateName":"Global Pharma & Logistic S.A.S.","url":"https:\/\/global-pharma.com.co\/","logo":{"@type":"ImageObject","inLanguage":"es-CO","@id":"https:\/\/global-pharma.com.co\/#\/schema\/logo\/image\/","url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2025\/08\/LOGO-COMPLETO2-02.jpg","contentUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2025\/08\/LOGO-COMPLETO2-02.jpg","width":2133,"height":2133,"caption":"Global Pharma & Logistic S.A.S."},"image":{"@id":"https:\/\/global-pharma.com.co\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/51710617\/admin\/dashboard\/"]},{"@type":"Person","@id":"https:\/\/global-pharma.com.co\/#\/schema\/person\/912625696b849a3374bc496e1df87a7c","name":"Mar\u00eda Camila Sanchez","image":{"@type":"ImageObject","inLanguage":"es-CO","@id":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","caption":"Mar\u00eda Camila Sanchez"},"url":"https:\/\/global-pharma.com.co\/es\/author\/maria-sanchez\/"}]}},"_links":{"self":[{"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/posts\/1913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/comments?post=1913"}],"version-history":[{"count":4,"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/posts\/1913\/revisions"}],"predecessor-version":[{"id":2159,"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/posts\/1913\/revisions\/2159"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/media\/2079"}],"wp:attachment":[{"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/media?parent=1913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/categories?post=1913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/global-pharma.com.co\/es\/wp-json\/wp\/v2\/tags?post=1913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}